Founded in 1888 A.D., it is a well-known chain pharmacy in China, a subsidiary of China National Pharmaceutical Group, a famous trademark in Guizhou Province, an intangible cultural heritage, and a well-known time-honored brand in Guizhou's traditional Chinese medicine industry
Sinopharm Tongjitang (Guizhou) Pharmaceutical Co., Ltd., a subsidiary of China National Pharmaceutical Group, is a high-tech state-owned mixed-ownership enterprise integrating planting, production, scientific research and sales.
Tongjitang was founded in the 14th year of Guangxu in the Qing Dynasty (1888 AD), and has a long history of more than 120 years, and is a well-known time-honored brand in Guizhou's traditional Chinese medicine industry. For more than 100 years, Tongjitang has always adhered to the characteristics of traditional Chinese medicine and promoted the culture of Chinese medicine. It is well-known inside and outside the province for its excellent quality and convenient service. It is the first pharmaceutical enterprise in Guizhou Province to be awarded the honor of "China Time-honored Brand" by the state. In 2008, Tongjitang's traditional Chinese medicine culture was included in the list of the "Second Batch of National Intangible Cultural Heritage" and became an intangible cultural heritage under national key protection.
Sinopharm Tongjitang (Guizhou) Pharmaceutical Co., Ltd. has established pharmaceutical production bases in Xiuwen County, Guiyang City and Xiaohe District, Guiyang City, respectively, with 11 GMP-certified production lines, which can produce 12 dosage forms such as capsules, tablets, granules, lozenges, syrup, tinctures, oral solutions, and ointments. At present, the company has invested 900 million yuan in Fuguan Village, Economic Development Zone, Guiyang City, to build a new Tongjitang orthopedic traditional Chinese medicine production base, which covers an area of 181,100 square meters, and will have an annual production capacity of 10 billion capsules after completion and operation, becoming the largest solid preparation production base in the three southwestern provinces.
At present, the company has more than 140 kinds of Chinese and Western medicines, and seven patented products with independent intellectual property rights. Among them, 11 modern Chinese medicines and 59 western medicines are included in the National Basic Medical Insurance and Work-related Injury Insurance Drug Catalogue. "Xianling Gubao Capsule (Tablet)", "Neck Shu Granule", "Moisturizing and Antipruritic Capsule", "Zao Ren Anshen Capsule" and "Rheumatism Bone Pain Capsule (Tablet)" were respectively included in the "2012 edition of the National Essential Medicines List" as exclusive varieties. Each product enjoys a high reputation in the national pharmaceutical market by virtue of its exact and significant curative effect, and the brands of "Tongjitang", "Xianling" and "Xianling Gubao" have become well-known protection.
In terms of new product research and development, we have invested a lot of money to build a new central laboratory that meets the requirements of GLP for the development of new drugs and the secondary development of existing drugs.
Since 1998, the company has successively won the titles of "Guiyang Civilized Unit", "Top 100 Enterprises in Guizhou Province", "Key Leading Enterprise of Agricultural Industrialization in Guiyang City", "Advanced Tax Unit in Guizhou Province", "Advanced Enterprise in Guizhou Province (County)", "Special Triple A Credit Unit of Agricultural Bank of Guizhou Province", "Guiyang City Contract and Trustworthy Enterprise", "Guiyang City Non-public Advantage Enterprise" and so on. "Xianling Gubao Capsule" has filled the gap in the treatment of osteoporosis with Chinese patent medicine, and has won the first prize of scientific and technological progress of the "World Federation of Orthopedics and Traumatology", the special contribution award of the "Chinese Orthopedic Association", the first prize of excellent products in Guizhou Province, the first prize of "Guiyang Science and Technology Innovation First Prize", "Guiyang Science and Technology Innovation Special Award" and many other honors.
After several baptisms in the pharmaceutical industry, Tongjitang Company is taking a more solid step towards "building a platform of 10 billion yuan of traditional Chinese medicine and becoming a leader in the traditional Chinese medicine industry".
